|
| Author | Year | Country | Diagnosis of RF | Renal failure clinical stage in MM patient | Dialysis or not before ASCT | Therapy | Prognostic criteria |
|
| ASCT in myeloma patients with renal insufficiency: the cohort studies |
| Antlanger et al. [29] | 2018 | Austria | (MDRD) | ISS stage
I (14%)
II (30%)
III (54%) | Not | Conventional chemotherapy+ASCT | eGFR (MDRD) |
| Gertz et al. [28] | 2007 | USA | | ISS stage
I (0%)
II (20%)
III (80%) | Not | Conditioning regimen (Mel)+ASCT | NR |
| Knudsen et al. [16] | 2015 | Denmark | | ISS stage
II (8%)
III (21%) | NR | Conditioning regimen (Mel)+ASCT | NR |
| Mahindra et al. [27] | 2017 | USA | (MDRD) | Severe RF | Not | Conditioning regimen (Mel)+ASCT | NR |
| Raab et al. [25] | 2006 | USA | | ISS stage
I (14%)
II (10%)
III (74%) | NR | Conditioning regimen (Mel)+ASCT | NR |
| San Miguel et al. [26] | 2000 | Spanish | | ISS stage
II (14%)
III (86%) | Not | Conditioning regimen (Mel)+ASCT | CrCl |
|
| ASCT in myeloma patients with renal insufficiency: the retrospective analysis studies |
| Badros et al. [32] | 2001 | USA | | NR | Not | Conditioning regimen (Mel)+ASCT | NR |
| Augeul-Meunier et al. [30] | 2018 | France | | NR | Dialysis dependence (47%) | Conditioning regimen (Mel)+ASCT | NR |
| Ballester et al. [34] | 1997 | USA | | NR | Dialysis dependence (67%) | BUCY+ASCT | SCr |
| Balsam et al. [35] | 2017 | USA | GFR | CKD stage
Stage 1 (31.8%)
Stage 2 (43.8%)
Stage 3 (17.7%)
Stage 4 (3.1%)
Stage 5 (1.6%) | Not | Conventional chemotherapy+ASCT | GFR |
| Bernard et al. [18] | 2015 | Canada | NR | NR | Not | Conditioning regimen (Mel)+ASCT | NR |
| Glavey et al. [36] | 2011 | USA | | ISS stage
I (14%)
II (10%)
III (74%) | Dialysis dependence (53%) | Conditioning regimen (Mel)+ASCT | CrCl |
| Seok Hui et al. [47] | 2011 | Korea | eGFR (MDRD) | CKD stage
IIIa (78%)
IIIb (12%) | Not | Conditioning regimen (Mel)+ASCT | eGFR (MDRD) |
| Parikh et al. [33] | 2009 | USA | | NR | Dialysis dependence (20%) | Conditioning regimen (Mel)+ASCT | eGFR (MDRD) |
| Tosi et al. [31] | 2000 | Italy | | CKD stage
IIIb (100%) | Not | Conventional chemotherapy+ASCT | CrCl |
|
| ASCT in myeloma patients with renal insufficiency: the case report studies |
| Bigé et al. [39] | 2009 | France | SCr | Acute renal failure | Not | Conditioning regimen (Mel)+ASCT | SCr |
| Lam et al. [38] | 2004 | China | Normal renal function | Normal renal function | Not | ASCT | NR |
| Rebibou et al. [40] | 1997 | France | NR | Severe renal failure | Not | Conditioning regimen (Mel)+ASCT | NR |
| Reiter et al. [37] | 1999 | Austria | NR | NR | Not | Conditioning regimen (VAD)+ASCT | CrCl |
| Tauro et al. [41] | 2002 | UK | NR | NR | Not | Conditioning regimen (Mel)+ASCT | SCr |
|
